Autopsy report · NCT05838703
Tiotropium Handihaler vs. Tiotropium Respimat in COPD
Cause of deathFunding or business
“Study halted prematurely due to funding, prior to enrollment of first participant”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Duke University
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- tiotropium bromide inhalation powder (Spiriva HandiHaler); tiotropium bromide (Spiriva Respimat); Hyperpolarized 129XeMRI
- Participants
- 0
Trials that died the same way
- Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)
“Study halted prematurely, prior to enrollment of first participant” - Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients
“Study stopped before submission for funding reasons” - High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac Surgery
“Study halted prematurely, prior to enrollment of first patient, due to recruiting problems.” - A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
“Due to low enrollment, the Sponsor decided to prematurely terminate the study” - Sciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine Micropellet
“Loss of funding- Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.